Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mohammad Ebrahimi Kalan, Jian Han, Ziyad Ben Taleb, Kristopher P Fennie, Mohammad Asghari Jafarabadi, Maryam Dastoorpoor, Nima Hajhashemi, Mitra Naseh & Shahnaz Rimaz. (2019) Quality Of Life And Stigma Among People Living With HIV/AIDS In Iran. HIV/AIDS - Research and Palliative Care 11, pages 287-298.
Read now
Read now
Farzad Jalali, Reza Afshari & Ali Babaei. (2014) Smoking Crushed Hyoscine/Scopolamine Tablets as Drug Abuse. Substance Use & Misuse 49:7, pages 793-797.
Read now
Read now
Articles from other publishers (26)
Fatemeh Tavakoli, Willi Mcfarland, Nima Ghalekhani, Mehrdad Khezri, Ali Akbar Haghdoost, Mohammad Mehdi Gouya, Marzieh Mahboobi, Ali Mohammad Hosseionpour, Ali Komasi, Mehdi Ghorbanian, Nasim Nasiri Moghadam, Maryam Taghipour & Hamid Sharifi. (2023) Double counting of clients using services in Iran: implications for assessing the reach of harm reduction programs. Harm Reduction Journal 20:1.
Crossref
Crossref
Nikolaos Boumparis, Alireza Noroozi, Eisa Naghizadeh, Andreas Meyer, Andreas Wenger, Afarin Rahimi-Movaghar & Michael P. Schaub. (2023) Blended smartphone intervention for patients in opioid maintenance treatment in Iran: protocol for a randomized controlled trial. BMC Psychiatry 23:1.
Crossref
Crossref
Mostafa Amini-Rarani, Maryam Moeeni & Koen Ponnet. (2023) Male patients’ preferences for opioid use treatment programs. BMC Psychiatry 23:1.
Crossref
Crossref
Mohammad Arezoomandan, Rahele Zhiani, Jamshid Mehrzad, Alireza Motavalizadehkakhky, Sahar Eshrati & Reza Arezoomandan. (2022) Inflammatory, oxidative stress and cognitive functions in patients under maintenance treatment with methadone or buprenorphine and healthy subjects. Journal of Clinical Neuroscience 101, pages 57-62.
Crossref
Crossref
Jude Alawa, Muzzammil Muhammad, Maryam Kazemitabar, Daniel J Bromberg, Danilo Garcia, Kaveh Khoshnood & Lilian Ghandour. (2022) Medication for opioid use disorder in the Arab World: A systematic review. International Journal of Drug Policy 102, pages 103617.
Crossref
Crossref
Semvua B. Kilonzo, Daniel W. Gunda, David C. Majinge, Hyasinta Jaka, Paulina M. Manyiri, Fredrick Kalokola, Grahame Mtui, Elichilia R. Shao, Fatma A. Bakshi & Alex Stephano. (2021) Seroprevalence of hepatitis B virus infection, anti-HCV antibodies and HIV and knowledge among people who use drugs attending methadone therapy clinic in Tanzania; a cross-sectional study. BMC Infectious Diseases 21:1.
Crossref
Crossref
Hamed Ekhtiari, Alireza Noroozi, Ali Farhoudian, Seyed Ramin Radfar, Ahmad Hajebi, Saeed Sefatian, Mehran Zare‐bidoky, Emran Mohammad Razaghi, Azarakhsh Mokri, Afarin Rahimi‐Movaghar & Richard Rawson. (2019) The evolution of addiction treatment and harm reduction programs in Iran: a chaotic response or a synergistic diversity?. Addiction 115:7, pages 1395-1403.
Crossref
Crossref
Maziyar Ghiabi. 2019. Drugs Politics. Drugs Politics.
Fatemeh Kazemi, Seyedeh Ameneh Motalebi, Moniralsadat Mirzadeh & Fatemeh Mohammadi. (2018) Predisposing factors for substance abuse among elderly people referring to Qazvin addiction treatment centers, Iran (2017). The Journal of Qazvin University of Medical Sciences 22:5, pages 26-35.
Crossref
Crossref
Thaísa Borges Gomes & Marcelo Dalla Vecchia. (2018) Estratégias de redução de danos no uso prejudicial de álcool e outras drogas: revisão de literatura. Ciência & Saúde Coletiva 23:7, pages 2327-2338.
Crossref
Crossref
Armita Shahesmaeili, Ali Mirzazadeh, Willi McFarland, Hamid Sharifi, Ali Akbar Haghdoost & Hamid Soori. (2018) Syringe Sharing in Drug Injecting Dyads: A Cross-Classified Multilevel Analysis of Social Networks. AIDS and Behavior 22:S1, pages 10-18.
Crossref
Crossref
Ali Ghaddar, Zeinab Abbas & Ramzi Haddad. (2017) Opiate agonist treatment to improve health of individuals with opioid use disorder in Lebanon. Harm Reduction Journal 14:1.
Crossref
Crossref
Kaina Zhou, Duolao Wang, Hengxin Li, Xiaoli Wei, Juan Yin, Peifeng Liang, Lingling Kou, Mengmeng Hao, Lijuan You, Xiaomei Li & Guihua Zhuang. (2017) Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment. PLOS ONE 12:6, pages e0179009.
Crossref
Crossref
Azarakhsh Mokri, Marek C. Chawarski, Hamidreza Taherinakhost & Richard S. Schottenfeld. (2016) Medical treatments for opioid use disorder in Iran: a randomized, double-blind placebo-controlled comparison of buprenorphine/naloxone and naltrexone maintenance treatment. Addiction 111:5, pages 874-882.
Crossref
Crossref
Mohammad Bagher Saberi Zafarghandi, Mohsen Jadidi & Narjes Khalili. (2015) Iran’s Activities on Prevention, Treatment and Harm Reduction of Drug Abuse. International Journal of High Risk Behaviors and Addiction 4:4.
Crossref
Crossref
Lei Zhang, Xia Zou, Di Zhang, Xiaoling Li, Peizhen Zhao & Li Ling. (2015) Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China. PLOS ONE 10:10, pages e0139942.
Crossref
Crossref
Zahra Alam-mehrjerdi, Mohammad Abdollahi, Peter Higgs & Kate Dolan. (2015) Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country. Asian Journal of Psychiatry 16, pages 78-83.
Crossref
Crossref
Sheena G. Sullivan, Zunyou Wu, Keming Rou, Lin Pang, Wei Luo, Changhe Wang, Xiaobin Cao, Wenyuan Yin, Enwu Liu & Guodong Mi. (2015) Who uses methadone services in China? Monitoring the world's largest methadone programme. Addiction 110, pages 29-39.
Crossref
Crossref
Seonaid Nolan, Viviane Dias Lima, Nadia Fairbairn, Thomas Kerr, Julio Montaner, Jason Grebely & Evan Wood. (2014) The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users. Addiction 109:12, pages 2053-2059.
Crossref
Crossref
Arsia Taghva, Farhad Amnollahi, Alireza Khoshdel, Mohammad Reza Kazemi & Kamyab Alizadeh. (2014) Cardiologists' Knowledge and Attitudes About Methadone and Buprenorphine Maintenance Treatment: A Survey Study in Tehran, Iran. Thrita 3:4.
Crossref
Crossref
Hamid-Reza Esmaeili, Hassan Ziaddinni, Mohammad-Rafee Nikravesh, Mohammad-Reza Baneshi & Nouzar Nakhaee. (2014) Outcome evaluation of the opioid agonist maintenance treatment in Iran. Drug and Alcohol Review 33:2, pages 186-193.
Crossref
Crossref
Ali Mirzazadeh, Saharnaz Nedjat, Soodabeh Navadeh, AliAkbar Haghdoost, Mohammad-Ali Mansournia, Willi McFarland & Kazem Mohammad. (2013) HIV and Related Risk Behaviors Among Female Sex Workers in Iran: Bias-Adjusted Estimates from the 2010 National Bio-Behavoral Survey. AIDS and Behavior 18:S1, pages 19-24.
Crossref
Crossref
Rab Nawaz Samo, Arshad Altaf, Ajmal Agha, Omrana Pasha, Shafquat Rozi, Ashraf Memon, Saleem Azam, Meridith Blevins, Sten H. Vermund & Sharaf Ali Shah. (2013) High HIV Incidence among Persons Who Inject Drugs in Pakistan: Greater Risk with Needle Sharing and Injecting Frequently among the Homeless. PLoS ONE 8:12, pages e81715.
Crossref
Crossref
Gilberto Gerra & Lorenzo Somaini. (2013) A comprehensive approach to addiction medicine as an appropriate response to the HIV epidemic among drug users. Journal of Food and Drug Analysis 21:4, pages S109-S112.
Crossref
Crossref
Zahra Alam Mehrjerdi. (2013) Norjizak Injection: A Critical Risk for Transmitting Blood-Borne Infectious Diseases. Hepatitis Monthly 13:4.
Crossref
Crossref
Azizbek A. Boltaev, Anna P. Deryabina, Almas Kusainov & Andrea A. Howard. (2012) Evaluation of a Pilot Medication-Assisted Therapy Program in Kazakhstan: Successes, Challenges, and Opportunities for Scaleup. Advances in Preventive Medicine 2012, pages 1-13.
Crossref
Crossref